Special
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
Trump Administration’s CDC Layoffs Shutter STD Lab, Sending Ripples Through Biotech and Global Health
2025-04-17
Leqembi Makes History as First EU-Approved Drug to Target Root Cause of Alzheimer’s Disease
2025-04-15
Uncovering the Mysteries of Parkinson’s Disease and the Hidden Factors Shaping Its Progression
2025-04-10
LATEST
Multiple PCV Doses May Be Needed for Immunocompromised Type 2 Diabetics to Maintain Protection, Study Finds
2025-04-19
Dr. Lauren Krupp, FAAN, Advocates Early Intervention and Family Support in Pediatric MS Treatment.
2025-04-19